Prospective association of 25(OH)D with metabolic syndrome

Clinical Endocrinology

Volumn 80, Issue 4, 2014, Pages 502-507

  Kayaniyil, Sheena ^a   Harris, Stewart B ^b   Retnakaran, Ravi ^c   Vieth, Reinhold ^a   Knight, Julia A ^a,d   Gerstein, Hertzel C ^e   Perkins, Bruce A ^c   Zinman, Bernard ^c,d   Hanley, Anthony J ^a,c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d MOUNT SINAI HOSPITAL   (Canada)

^e HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D;

ADULT; ARTICLE; COHORT ANALYSIS; ETHNICITY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PHYSICAL ACTIVITY; PRIORITY JOURNAL;

ADULT; BLOOD GLUCOSE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSULIN RESISTANCE; LINEAR MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84896764742     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12190     Document Type: Article

References (30)

1. Ford, E.S., Zhao, G., Li, C., et al,. (2009) Serum concentrations of vitamin D and parathyroid hormone and prevalent metabolic syndrome among adults in the United States. Journal of Diabetes, 1, 296-303.
2. Kim, M.K., Kang, M.I., Oh, K.W., et al,. (2010) The association of serum vitamin D level with presence of metabolic syndrome and hypertension in middle-aged Korean subjects. Clinical Endocrinology (Oxford), 73, 330-338.
3. Chacko, S.A., Song, Y., Manson, J.E., et al,. (2011) Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women. American Journal of Clinical Nutrition, 94, 209-217.
4. Hypponen, E., Boucher, B.J., Berry, D.J., et al,. (2008) 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes, 57, 298-305.
5. Kayaniyil, S., Vieth, R., Harris, S.B., et al,. (2011a) Association of 25(OH)D and PTH with metabolic syndrome and its traditional and nontraditional components. Journal of Clinical Endocrinology and Metabolism, 96, 168-175.
6. Oosterwerff, M.M., Eekhoff, E.M., Heymans, M.W., et al,. (2011) Serum 25-hydroxyvitamin D levels and the metabolic syndrome in older persons: a population-based study. Clinical Endocrinology (Oxford), 75, 608-613.
7. Brenner, D.R., Arora, P., Garcia-Bailo, B., et al,. (2011) Plasma vitamin D levels and risk of metabolic syndrome in Canadians. Clinical and Investigative Medicine, 34, E377.
8. Maki, K.C., Fulgoni, V.L. 3rd, Keast, D.R., et al,. (2012) Vitamin d intake and status are associated with lower prevalence of metabolic syndrome in U.S. adults: national health and nutrition examination surveys 2003-2006. Metabolic Syndrome and Related Disorders 10, 363-372.
9. Fung, G.J., Steffen, L.M., Zhou, X., et al,. (2012) Vitamin D intake is inversely related to risk of developing metabolic syndrome in African American and white men and women over 20 y: the Coronary Artery Risk Development in Young Adults study. American Journal of Clinical Nutrition, 96, 24-29.
10. Gagnon, C., Lu, Z.X., Magliano, D.J., et al,. (2012) Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab). Journal of Clinical Endocrinology and Metabolism, 97, 1953-1961.
11. Skaaby, T., Husemoen, L.L., Pisinger, C., et al,. (2012) Vitamin D status and changes in cardiovascular risk factors: a prospective study of a general population. Cardiology, 123, 62-70.
12. Forouhi, N.G., Luan, J., Cooper, A., et al,. (2008) Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes, 57, 2619-2625.
13. Hjelmesaeth, J., Hofso, D., Aasheim, E.T., et al,. (2009) Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study. Cardiovascular Diabetology, 8, 7.
14. Reis, J.P., von Muhlen, D., Kritz-Silverstein, D., et al,. (2007) Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care, 30, 1549-1555.
15. Rueda, S., Fernandez-Fernandez, C., Romero, F., et al,. (2008) Vitamin D, PTH, and the metabolic syndrome in severely obese subjects. Obesity Surgery, 18, 151-154.
16. Kayaniyil, S., Retnakaran, R., Harris, S.B., et al,. (2011b) Prospective associations of vitamin D with beta-cell function and glycemia: the PROspective Metabolism and ISlet cell Evaluation (PROMISE) cohort study. Diabetes, 60, 2947-2953.
17. Wagner, D., Hanwell, H.E., &, Vieth, R., (2009) An evaluation of automated methods for measurement of serum 25-hydroxyvitamin D. Clinical Biochemistry, 42, 1549-1556.
18. Kriska, A.M., Knowler, W.C., LaPorte, R.E., et al,. (1990) Development of questionnaire to examine relationship of physical activity and diabetes in Pima Indians. Diabetes Care, 13, 401-411.
19. Alberti, K.G., Eckel, R.H., Grundy, S.M., et al,. (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation, 120, 1640-1645.
20. Holick, M.F., Binkley, N.C., Bischoff-Ferrari, H.A., et al,. (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 96, 1911-1930.
21. Forouhi, N.G., Ye, Z., Rickard, A.P., et al,. (2012) Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies. Diabetologia, 55, 2173-2182.
22. Gagnon, C., Lu, Z.X., Magliano, D.J., et al,. (2011) Serum 25-Hydroxyvitamin D, calcium Intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian Diabetes, Obesity and Lifestyle Study). Diabetes Care, 34, 1133-1138.
23. Kayaniyil, S., Vieth, R., Retnakaran, R., et al,. (2010) Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care, 33, 1379-1381.
24. Nam, G.E., Kim, D.H., Cho, K.H., et al,. (2012) 25-Hydroxyvitamin D insufficiency is associated with cardiometabolic risk in Korean adolescents: the 2008-2009 Korea National Health and Nutrition Examination Survey (KNHANES). Public Health Nutrition, 1-9 [Epub ahead of print].
25. Makariou, S., Liberopoulos, E., Florentin, M., et al,. (2012) The relationship of vitamin D with non-traditional risk factors for cardiovascular disease in subjects with metabolic syndrome. Archives of Medical Science, 8, 437-443.
26. Salehpour, A., Shidfar, F., Hosseinpanah, F., et al,. (2012) Vitamin D3 and the risk of CVD in overweight and obese women: a randomised controlled trial. British Journal of Nutrition, 108, 1866-1873.
27. Jorde, R., Sneve, M., Torjesen, P., et al,. (2010a) No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year. Journal of Internal Medicine, 267, 462-472.
28. Jorde, R., Sneve, M., Torjesen, P.A., et al,. (2010b) No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects. Cytokine, 50, 175-180.
29. Shab-Bidar, S., Neyestani, T.R., Djazayery, A., et al,. (2012) Improvement of vitamin D status resulted in amelioration of biomarkers of systemic inflammation in the subjects with type 2 diabetes. Diabetes/Metabolism Research and Reviews, 28, 424-430.
30. Neyestani, T.R., Nikooyeh, B., Alavi-Majd, H., et al,. (2012) Improvement of vitamin D status via daily intake of fortified yogurt drink either with or without extra calcium ameliorates systemic inflammatory biomarkers, including adipokines, in the subjects with type 2 diabetes. Journal of Clinical Endocrinology and Metabolism, 97, 2005-2011.